Yazdizadeh Bahareh, Jarrahi Alireza Mosavi, Mortazavi Hossein, Mohagheghi Mohammad Ali, Tahmasebi Soroush, Nahvijo Azin
The Cancer Institute Research Center, the Imam Khomeini Medical Center, P.O. Box 18575-4194, Tehran, I. R. of Iran.
Asian Pac J Cancer Prev. 2005 Apr-Jun;6(2):130-4.
The aim of this study was to study the changes in occurrence of esophageal, stomach and colon cancers (cancers of interest) over the last 30 years in Iran.
Cancer cases referred to two main cancer centers in the country (the Shiraz cancer center and the Tehran cancer center) during last 30 years and published by the two centers were utilized. Morbidity odds ratios (MOR) were used to study trend in the occurrence of each cancer site in each center. For this purpose the cancers of interest were considered as cases; childhood cancers as controls; and calendar year as exposure. A regression line was fitted to morbidity odds ratios over years and the slope of the regression line was considered to indicate the overall trend. MORs and 95% CIs comparing the last five and first five years were computed to measure the magnitude of the change over time.
The overall trend for esophageal cancer was decrease (slopes = -0.02 for Shiraz and -0.03 for Tehran); for stomach was increase (slopes = 0.04 for Shiraz and 0.08 for Tehran), and for colon cancer was sharp increase (slopes = 0.02 for Shiraz and 0.10 for Tehran). The magnitude of changes showed stomach cancer to increase by 35% in Shiraz (MOR = 1.35 with 95% CI 1.1, 1.65) and 13% in Tehran (MOR = 1.13 with 95% CI 0.96, 1.38), esophageal cancer to decrease by 20% in Shiraz (MOR = 0.82 with 95% CI 0.62, 1.11) and 50% in Tehran (MOR = 0.52 with 95% CI 0.45, 0.60), and colon cancer to increase by 65% in Shiraz (MOR = 1.65 with 95% CI 1.26, 2.16) and 82% in Tehran (MOR = 1.82 with 95% CI 1.52, 2.25).
During the last thirty years the occurrence of major GI cancers has changed in Iran with sharp increase in colon cancer, slight to moderate increase in stomach cancer and sharp decrease in esophageal cancer.
本研究旨在探讨过去30年伊朗食管癌、胃癌和结肠癌(目标癌症)发病率的变化情况。
利用该国两个主要癌症中心(设拉子癌症中心和德黑兰癌症中心)在过去30年所收治并发表的癌症病例。发病率比值比(MOR)用于研究各中心每个癌症部位发病率的变化趋势。为此,将目标癌症视为病例;儿童癌症作为对照;历年作为暴露因素。对多年的发病率比值比拟合回归线,回归线的斜率被视为代表总体趋势。计算并比较最近五年和最初五年的MOR及95%置信区间(CI),以衡量随时间变化的幅度。
食管癌的总体趋势是下降(设拉子的斜率=-0.02,德黑兰的斜率=-0.03);胃癌呈上升趋势(设拉子的斜率=0.04,德黑兰的斜率=0.08),结肠癌则急剧上升(设拉子的斜率=0.02,德黑兰的斜率=0.10)。变化幅度显示,设拉子胃癌增加了35%(MOR=1.35,95%CI为1.1,1.65),德黑兰增加了13%(MOR=1.13,95%CI为0.96,1.38);设拉子食管癌下降了20%(MOR=0.82,95%CI为0.62,1.11),德黑兰下降了50%(MOR=0.52,95%CI为0.45,0.60);设拉子结肠癌增加了65%(MOR=1.65,95%CI为1.26,2.16),德黑兰增加了82%(MOR=1.82,95%CI为1.52,2.25)。
在过去三十年中,伊朗主要胃肠道癌症的发病率发生了变化,结肠癌急剧增加,胃癌有轻微至中度增加,食管癌急剧下降。